165 related articles for article (PubMed ID: 8750543)
21. Treatment in Lambert-Eaton myasthenic syndrome.
Maddison P
Ann N Y Acad Sci; 2012 Dec; 1275():78-84. PubMed ID: 23278581
[TBL] [Abstract][Full Text] [Related]
22. [Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
Matsushima M; Yaguchi H; Kishimoto R; Tsuji S; Yabe I; Sasaki H; Nakadate M; Shiraishi H; Motomura M
Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1709-11. PubMed ID: 17802724
[No Abstract] [Full Text] [Related]
23. Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome before and after 3,4-diaminopyridine.
Sadeh M; River Y; Argov Z
Muscle Nerve; 1997 Jun; 20(6):735-9. PubMed ID: 9149081
[TBL] [Abstract][Full Text] [Related]
24. Practical aspects of 3,4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome.
Lundh H; Nilsson O; Rosén I; Johansson S
Acta Neurol Scand; 1993 Aug; 88(2):136-40. PubMed ID: 8213058
[TBL] [Abstract][Full Text] [Related]
25. [A case of Lambert-Eaton myasthenic syndrome with small cell lung cancer, treated with 3,4-diaminopyridine].
Uekita K; Ishida T; Sekine S; Ishii T; Sato S; Sugawara A; Tachihara M; Watanabe K; Kanazawa K; Saito J; Tanino Y; Munakata M
Nihon Kokyuki Gakkai Zasshi; 2009 Jan; 47(1):76-80. PubMed ID: 19198242
[TBL] [Abstract][Full Text] [Related]
26. Acute ventilatory failure in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine.
Smith AG; Wald J
Neurology; 1996 Apr; 46(4):1143-5. PubMed ID: 8780107
[TBL] [Abstract][Full Text] [Related]
27. Lambert-Eaton myasthenic syndrome: evaluation of movement performance following drug therapy.
Cooke JD; Hefter H; Brown SH; Toyka KV; Freund HJ
Electromyogr Clin Neurophysiol; 1994 Mar; 34(2):87-93. PubMed ID: 8187683
[No Abstract] [Full Text] [Related]
28. Myasthenia gravis and myasthenic syndrome.
Antozzi C
Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
[TBL] [Abstract][Full Text] [Related]
29. Lambert Eaton syndrome: autonomic neuropathy and inappropriate antidiuretic hormone secretion in a patient with small cell carcinoma of the lung.
Manji H; Schwartz MS; McKeran RO
J Neurol; 1990 Aug; 237(5):324-5. PubMed ID: 2172471
[TBL] [Abstract][Full Text] [Related]
30. Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment.
Tim RW; Massey JM; Sanders DB
Neurology; 2000 Jun; 54(11):2176-8. PubMed ID: 10851390
[TBL] [Abstract][Full Text] [Related]
31. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2005 Apr; (2):CD003279. PubMed ID: 15846654
[TBL] [Abstract][Full Text] [Related]
32. 3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trials.
Zhang N; Hong D; Ouyang T; Meng W; Huang J; Li M; Hong T
BMC Neurol; 2021 Sep; 21(1):371. PubMed ID: 34563155
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
34. [Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine].
Jost WH; Mielke U; Forrett-Kaminsky MC; Schimrigk K
Rev Neurol (Paris); 1992; 148(12):776-9. PubMed ID: 1303573
[TBL] [Abstract][Full Text] [Related]
35. [Myasthenia-like syndromes: current and future treatments].
Kuntzer T; Pedrazzi P
Praxis (Bern 1994); 1995 Sep; 84(38):1042-9. PubMed ID: 7481303
[TBL] [Abstract][Full Text] [Related]
36. Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J; Mills KR
Muscle Nerve; 1998 Sep; 21(9):1196-8. PubMed ID: 9703446
[TBL] [Abstract][Full Text] [Related]
37. Management of myasthenic conditions: nonimmune issues.
Argov Z
Curr Opin Neurol; 2009 Oct; 22(5):493-7. PubMed ID: 19593127
[TBL] [Abstract][Full Text] [Related]
38. [A retrospective study of the effects of 3,4-diaminopyridine treatment in Lambert-Eaton myasthenic syndrome].
Naganuma R; Yabe I; Takahashi I; Matsushima M; Kano T; Sasaki H
Rinsho Shinkeigaku; 2018 Feb; 58(2):83-87. PubMed ID: 29386498
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison.
Jost WH; Mielke U; Schimrigk K
Wien Klin Wochenschr; 1991; 103(20):629-32. PubMed ID: 1763511
[TBL] [Abstract][Full Text] [Related]
40. 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS.
Oh SJ; Claussen GG; Hatanaka Y; Morgan MB
Muscle Nerve; 2009 Nov; 40(5):795-800. PubMed ID: 19722254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
